Clinical Trial Update: UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX) [Phase 2, Phase 3]

View source ↗

Summary

UCMSCs are being studied as a treatment for acute ischemic stroke in Phase 2 and Phase 3 trials. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• UCMSCs (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Cytopeutics Sdn. Bhd. | Conditions: Acute Ischemic Stroke | Phase 2, Phase 3 | Status: RECRUITING